Skip to main content

eTMF market to grow sizably over next three years, ISR reports

By March 9th, 2022No Comments

The adoption of eTMF solutions is accelerating – with more than 50% of investigative sites expected to have access to a sponsor/CRO eTMF application within three years.

This figure is according to a recent report published by Industry Standard Research (ISR), which assessed eTMF (electronic trial master file) application access to be around 20% today.

Andrew Schafer, President, Industry Standard Research (ISR) said the driving demand is “simply an evolution” of pharmaceutical and service providers to web-based applications.

Schafer compared the shift in the market to the adoption curve of other eClinical technologies, such as EDC, eCOA, ePRO and IRT/IVR.

Continue reading at: